EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024.

Claudia Adriana Colín-Castro, Luis Esaú López-Jácome iD, María José Rodríguez-García, Melissa Garibaldi-Rojas, Fabián Rojas-Larios iD, María Del Rosario Vázquez-Larios, Sandra Quintana-Ponce, Rafael Franco-Cendejas iD, Adolfo Gómez-Quiróz, Patricia Rodríguez-Zulueta, Thalia Rosado-Espinosa, Luis Javier Quintanilla-Cazares und 39 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Claudia Adriana Colín-Castro und 50 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Drug Resistance, Multiple, Bacterial, Drug Resistance, Microbial. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Científico Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antimicrobial resistance surveillance plays an important role in generating information about the prevalence of resistant microorganisms. In this study, we summarize a surveillance of antimicrobial resistance and carbapenemase-encoding genes for selected pathogens in Mexican healthcare centers.

Methods

Databases of identification and susceptibility results collected from January 1 to March 31, 2024, from forty-one centers were gathered and analyzed using the WHONET software. Some relevant gram-negatives and gram-positives, which were isolated from relevant clinical specimens were included. Isolates were stratified by patient´s age, clinical specimens, and site of attention, and were classified as multidrug-resistant (MDR). Clinical isolates were collected from January 1 to June 30 and were genotyped for carbapenemase-encoding genes by a polymerase chain reaction test.

Results

In total, 8 708 strains were included. Escherichia coli had a higher resistance to carbapenems ( p < 0.05) in the 0–17 years group and Klebsiella pneumoniae ( p = 0.017) , Pseudomonas aeruginosa, and Acinetobacter baumannii ( p < 0.05) in the 18–59 years group. P. aeruginosa had higher resistance to ceftazidime-avibactam, ceftolozane-tazobactam, cefepime, and imipenem ( p < 0.05) in the 18–59 years group. K. pneumoniae had the highest resistance to carbapenems ( p < 0.05) and cefepime ( p < 0.001) in clinical isolates recovered from blood. For P. aeruginosa, the highest resistance to cefepime ( p = 0.012) and ceftazidime ( p < 0.018) was seen in isolates from urine. For Staphylococcus aureus , a higher resistance was observed for cefoxitin in lower respiratory tract specimens ( p < 0.05). E. coli had the highest resistance to carbapenems ( p < 0.01), and P. aeruginosa for ceftazidime ( p = 0.005), cefepime ( p = 0.003), piperacillin-tazobactam ( p =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsDrug Resistance, Multiple, BacterialDrug Resistance, MicrobialHumansAdultAnti-Bacterial AgentsAdolescentMiddle AgedGenotypeMicrobial Sensitivity TestsChildInfantChild, PreschoolYoung AdultMaleFemaleMexicoInfant, NewbornKlebsiella pneumoniaeCarbapenemsPseudomonas aeruginosaAcinetobacter baumanniiEscherichia coli

Substanzen

carbapenemasebeta-LactamasesBacterial ProteinsAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
  • Departamento de Biología, Facultad de Química. Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico.
  • Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina. Monterrey, Nuevo León. Mexico.
  • Universidad de Colima, Colima, Colima, Mexico.
  • Hospital Regional Universitario de los Servicios de Salud del Estado de Colima, Colima, Colima, Mexico.

ORCID-Profile: Luis Esaú López-Jácome, Fabián Rojas-Larios, Rafael Franco-Cendejas, Pablo Hernan Sandoval-Villaseñor, Juan Pablo Mena-Ramírez, Bernardo A Martínez-Guerra, Nicolás Rogelio Eric Barlandas-Rendón, Elvira Garza-González

Förderung

  • Instituto Científico Pfizer

Zitieren

APA

Colín-Castro, C. A., López-Jácome, L. E., Rodríguez-García, M. J., Garibaldi-Rojas, M., Rojas-Larios, F., Vázquez-Larios, M. D. R., Quintana-Ponce, S., Franco-Cendejas, R., Gómez-Quiróz, A., Rodríguez-Zulueta, P., Rosado-Espinosa, T., Quintanilla-Cazares, L. J., Velázquez-Acosta, C., Sandoval-Villaseñor, P. H., Mena-Ramírez, J. P., Choy-Chang, E. V., González-Lara, M. F., Martínez-Guerra, B. A., Bolado-Martínez, E., …, & Garza-González, E. (2025). The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024. PLOS ONE. https://doi.org/10.1371/journal.pone.0319441

Vancouver

Colín-Castro CA, López-Jácome LE, Rodríguez-García MJ, Garibaldi-Rojas M, Rojas-Larios F, Vázquez-Larios MDR, et al. The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024. PLOS ONE. 2025. doi:10.1371/journal.pone.0319441

BibTeX
@article{ColnCastro2025,
  author = {Colín-Castro, Claudia Adriana and López-Jácome, Luis Esaú and Rodríguez-García, María José and Garibaldi-Rojas, Melissa and Rojas-Larios, Fabián and Vázquez-Larios, María Del Rosario and Quintana-Ponce, Sandra and Franco-Cendejas, Rafael and Gómez-Quiróz, Adolfo and Rodríguez-Zulueta, Patricia and Rosado-Espinosa, Thalia and Quintanilla-Cazares, Luis Javier and Velázquez-Acosta, Consuelo and Sandoval-Villaseñor, Pablo Hernan and Mena-Ramírez, Juan Pablo and Choy-Chang, Elena Victoria and González-Lara, María Fernanda and Martínez-Guerra, Bernardo A and Bolado-Martínez, Enrique and Aviles-Benítez, Laura Karina and Feliciano-Guzmán, José Manuel and Couoh-May, Carlos Antonio and Pérez-Vicelis, Talia and Silva-Gamiño, Aldo Rafael and Rivera-Garay, Luis Raúl and Navarro-Vargas, Norberta Vianey and Gutiérrez-Brito, Maricruz and Adame-Álvarez, César and Suárez-Moreno, Sandra María and Pérez-Vega, Bertha Alicia and López-Moreno, Laura Isabel and Jacobo-Baca, Guillermo and Galindo-Méndez, Mario and Ballesteros-Silva, María Bertha and Vázquez-Narvaez, Elda Gabriela and Barlandas-Rendón, Nicolás Rogelio Eric and Rodríguez-Balderas, Dora Elia and Castañeda-Duarte, Juan de Dios and Padilla-Ibarra, Cecilia and Peralta-Peñúñuri, Víctor Hugo and López-Vázquez, Alma Denia and Santiago-Calderón, María Asunción and Cecilia Valtierra, Ángela and González-Melgoza, Paulina Fabiola and Medina-Navarro, Luis Gerardo and Mireles-Dávalos, Christian Daniel and De-la-Cruz-Hernández, Ibis and Huirache-Villalobos, Guadalupe Soledad and Aguilar-Trejo, Ernesto Mario and López-Álvarez, María Del Rocío and Garza-González, Elvira},
  title = {The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319441}
}
Kostenlos starten →